UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000033887
Receipt number R000038652
Scientific Title Identification of novel serum biomarkers enabling differential diagnosis of non-alcoholic fatty liver disease
Date of disclosure of the study information 2018/08/24
Last modified on 2023/11/13 09:41:11

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Identification of novel serum biomarkers enabling differential diagnosis of non-alcoholic fatty liver disease

Acronym

Identification of novel serum biomarkers for NAFLD

Scientific Title

Identification of novel serum biomarkers enabling differential diagnosis of non-alcoholic fatty liver disease

Scientific Title:Acronym

Identification of novel serum biomarkers for NAFLD

Region

Japan


Condition

Condition

Non-alcoholic fatty liver disease

Classification by specialty

Hepato-biliary-pancreatic medicine Adult

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

We will compare the levels of novel serum biomarkers among healthy volunteers, simple steatosis patients, and non-alcoholic steatohepatitis patients to explore their usefulness for differential diagnosis of non-alcoholic fatty liver disease.

Basic objectives2

Others

Basic objectives -Others

We will compare the levels of novel serum biomarkers among healthy volunteers, simple steatosis patients, and non-alcoholic steatohepatitis patients to explore their usefulness for differential diagnosis of non-alcoholic fatty liver disease.

Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

We will quantitate the levels of novel serum biomarkers using the sera from healthy volunteers, simple steatosis patients, and non-alcoholic steatohepatitis patients. The results will be statistically analyzed to explore their usefulness.

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

3

Purpose of intervention

Diagnosis

Type of intervention

Device,equipment

Interventions/Control_1

Healthy volunteer
Abdominal ultrasound echo:Once
Blood draw:Once

Interventions/Control_2

Simple steatosis patient previously diagnosed by liver biopsy
Blood draw:Once

Interventions/Control_3

Non-alcoholic steatohepatitis patient previosly diagnosed by liver biopsy
Blood draw:Once

Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

40 years-old <=

Age-upper limit

69 years-old >=

Gender

Male and Female

Key inclusion criteria

Healthy volunteer
1)Written informed consent is required.
2)Individuals of 40-69 years old.

Patient of non-alcoholic fatty liver disease
1)Written informed consent is required.

Key exclusion criteria

Healthy volunteer
1)Individuals diagnosed as fatty liver by abdominal ultrasound echo.

Target sample size

10


Research contact person

Name of lead principal investigator

1st name Yuichi
Middle name
Last name Tsuchiya

Organization

Toho University School of Pharmaceutical Sciences

Division name

Department of Biochemistry

Zip code

2748510

Address

2-2-1 Miyama, Funabashi-shi, Chiba

TEL

047-472-9199

Email

tsuchiya@phar.toho-u.ac.jp


Public contact

Name of contact person

1st name Yuichi
Middle name
Last name Tsuchiya

Organization

Toho University School of Medicne

Division name

Division of Biochemistry, Department of Biochemistry

Zip code

2748510

Address

2-2-1 Miyama, Funabashi-shi, Chiba

TEL

047-472-9199

Homepage URL


Email

tsuchiya@phar.toho-u.ac.jp


Sponsor or person

Institute

Toho University

Institute

Department

Personal name



Funding Source

Organization

Ministry of Education, Culture, Sports, Science and Technology Japan

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

The ethical committee of Toho Unviersity School of Medicine

Address

5-21-16 Omori-nishi, Ota-ku, Tokyo

Tel

03-3762-4151

Email

med.rinri@ext.toho-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2018 Year 08 Month 24 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

27

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2018 Year 08 Month 03 Day

Date of IRB

2021 Year 03 Month 19 Day

Anticipated trial start date

2021 Year 03 Month 19 Day

Last follow-up date

2024 Year 03 Month 31 Day

Date of closure to data entry

2024 Year 03 Month 31 Day

Date trial data considered complete

2024 Year 03 Month 31 Day

Date analysis concluded

2024 Year 03 Month 31 Day


Other

Other related information

The original cilinical trial was once terminated on March 31, 2020. After the modification of study design, the clinical trial was restarted on March 19, 2021.
The reserachers are now developing new original monoclonal antibodies and a new ELISA system to improve the sensitivity.


Management information

Registered date

2018 Year 08 Month 24 Day

Last modified on

2023 Year 11 Month 13 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000038652


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name